Find Academic Supervisors

• Artificial Intelligence
• Machine Learning
• Signal Processing
• +4 more

Zachi Attia, Ph.D., M.B.A., is an Associate Professor at the Mayo Clinic College of Medicine and Science, Rochester, Minnesota. His research focuses on applying artificial intelligence (AI) and machine learning to cardiac biosignals, particularly for early disease detection and prediction. He holds primary and joint appointments as Consultant in AI within the Department of Cardiovascular Medicine, collaborating with the Center for Digital Health and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. Education: Ph.D. in Electrical Engineering from the University of Minnesota, Rochester; BSc and MSc in Electrical Engineering from Ben Gurion University, Israel. Dr. Attia's work centers on developing AI models that analyze multimodal cardiac data (ECGs, echocardiograms, angiograms) to detect silent diseases. His research includes pragmatic clinical trials to validate AI's impact on patient outcomes, explainable AI for biological insights, and integrating AI dashboards into medical records for clinical usability. Recent publications highlight AI applications in detecting atrial fibrillation, hypertrophic cardiomyopathy, and pulmonary hypertension via ECG analysis. Scientific Awards: No explicit awards mentioned in the text. Email: attia.itzhak@mayo.edu

• Vascular Biology
• Atherosclerosis
• Arterial Stiffness
• +2 more

Dr. Stella Daskalopoulou is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences. She specializes in translational cardiovascular research with a focus on vascular health, atherosclerosis, and hypertension management. Senior Scientist, RI-MUHC Glen site Professor, Department of Medicine, McGill University Member, Cardiovascular Health Across the Lifespan Program Research Focus: Her work integrates biomedical technology with clinical investigation to identify early vascular impairment markers. Key areas include: Arterial stiffness and hemodynamic assessment Adiponectin signaling pathways in atherosclerosis Sex-specific cardiovascular risk stratification Biomarker discovery for plaque instability Pregnancy-related vascular complications Machine learning applications in plaque classification Scientific Engagement: Dr. Daskalopoulou contributes to hypertension guideline development (2024 ESC Guidelines) and explores environmental impacts on vascular health (household pollution studies). Her recent publications emphasize: Deep learning for plaque characterization Sex hormone receptor pathways in atherosclerosis Adipokine interactions with HDL metabolism Clinical decision tools for preeclampsia prediction Laboratory: Leads the Vascular Health Unit at RI-MUHC, combining histopathology, immunophenotyping, and advanced imaging for translational research.

• Cardiovascular Physiology
• Exercise and Aging
• Hypertension
• +3 more

Joel D. Trinity, PhD, is an Associate Professor in the Department of Internal Medicine at the University of Utah and holds adjunct appointments in the Department of Nutrition and Integrative Physiology and the Department of Physical Therapy & Athletic Training. He is affiliated with the Geriatrics Division and the Utah Vascular Research Laboratory (UVRL), where he has been a member since 2009. Education: PhD – The University of Texas at Austin MA – The University of Texas at Austin BA – Occidental College BA – University of California, Santa Cruz Postdoctoral Fellowship – University of Utah Advanced Fellowship – George E. Whalen VA Medical Center Research Focus: Dr. Trinity’s laboratory employs integrative in-vivo and in-vitro methodologies to investigate how aging and chronic diseases—particularly hypertension, heart failure, COPD, and peripheral artery disease—impair vascular function and blood-flow regulation. His work emphasizes the triad of neural control, oxidative stress, and endothelial signaling (especially nitric oxide) in determining vascular health across the lifespan. Publications Snapshot: From 2021-2025, Dr. Trinity has published extensively on human cardiovascular responses to exercise, vascular aging, and the vascular consequences of COVID-19. A recurring theme is the translational evaluation of passive leg movement as a non-invasive probe of endothelial function, with studies spanning young adults to older patients with multiple comorbidities. Funding & Collaborations: While specific grant numbers are not provided, the breadth of multi-center collaborations (e.g., RECOVER Consortium for long COVID) and continuous publication output indicate active federal and institutional funding. His laboratory hosts interdisciplinary trainees bridging geriatrics, exercise physiology, and vascular biology. Laboratory & Teams: Dr. Trinity conducts research within the Utah Vascular Research Laboratory (UVRL), leveraging state-of-the-art Doppler ultrasound, plethysmography, and metabolic assays to dissect vascular control mechanisms in human participants and murine models.

John GreenwoodView profile

Professor

• Cardiovascular Research
• Cardiology
• Coronary Artery Disease
• +3 more

Professor John Greenwood serves as Director and Chief Executive of the Baker Heart and Diabetes Institute , with honorary professorships at the University of Melbourne , Monash University , and University of Leeds, UK . He is a consultant cardiologist specializing in coronary intervention and cardiovascular magnetic resonance (CMR) imaging . His research focuses on: Diagnosis and treatment of stable/unstable coronary artery disease CMR pulse sequence development and validation (CE-MARC trials) Multi-center drug/device trials for STEMI and complex coronary disease Machine learning applications in cardiac imaging Recent publications highlight trends in CMR-guided clinical decision-making, ischemic cardiomyopathy, and post-COVID-19 cardiac effects. Key awards include the SCMR Gold Medal (2023) and Honorary Life-Fellowships from the British Cardiovascular Society and Irish Cardiac Society. Professional Leadership: President of British Cardiovascular Society (2021–2024) Former BSCMR President (2018–2020) SCMR Guideline Committee Member (2018–2021) Advising : Supervised ~30 MD/PhD students. Grants : British Heart Foundation Clinical Research Collaborative, Heart Research UK.

• Cardio-Oncology
• Air Pollution and Cardiovascular Disease
• Space Medicine
• +5 more

Kazuaki Negishi is a Professor of Medicine and Head of the Discipline of Medicine at Sydney Medical School Nepean, University of Sydney's Faculty of Medicine and Health. He holds adjunct professorships at the University of Tasmania and is a board-certified cardiologist in Japan and Australia. His expertise spans cardio-oncology, air pollution-cardiovascular links, space medicine, and advanced imaging. Clinically, he practices at Nepean Hospital and previously led the Echo lab at Royal Hobart Hospital. He completed his MD and PhD in Japan, with additional training at Cleveland Clinic, USA. Research interests include cardiovascular imaging, subclinical myocardial insults, and health policy. He leads a team of 1 Senior Research Fellow, 2 Post-Doctoral fellows, and supervises PhD students across multiple institutions. Awards include the National Heart Foundation Future Leader Fellowship and international society recognitions (FACC, FESC, FAHA). Key collaborations include NASA, Gunma University (Japan), and the ANZACT Network. His work on SUCCOUR trials and REDUCE trial (sonothrombolysis) aims to improve cardiovascular outcomes in oncology patients. He chairs editorial boards for JACC: Cardiovascular Imaging and Journal of the American Society of Echocardiography .

• Cardiac Arrhythmias
• Heart Failure
• Exercise Physiology
• +3 more

Dr. Adrian Elliott is an Ext-Funded Research Fellow at the University of Adelaide's School of Biomedicine, within the Faculty of Health and Medical Sciences. He holds a National Heart Foundation Future Leader Fellowship and leads research on cardiac arrhythmias, particularly atrial fibrillation (AF) and heart failure (HF). His work emphasizes exercise interventions in AF management and explores mechanisms linking physical activity to cardiac health in athletes and patients. Dr. Elliott's research spans three core themes: 1) Exercise-based interventions for arrhythmias and HF, 2) Cardiac arrhythmias in endurance athletes, and 3) Pathophysiological mechanisms of arrhythmias and HF. He leads the EXIT-AF trial (exercise rehab post-AF ablation) and the LAST-AF study (subclinical HFpEF in AF patients). He also coordinates the Pro@Heart cohort study on elite athletes' cardiac remodeling. He has secured over $4M in grants, presents internationally, and supervises PhD students in the Centre for Heart Rhythm Disorders. His lab investigates left atrial dysfunction, HFpEF biomarkers, and exercise's impact on arrhythmia risk. Collaborations include SAHMRI, Royal Adelaide Hospital, and clinical trials like REDUCE-AF and PREDICT-STROKE.

• Cardiology
• Cardiovascular Imaging
• Health Economics
• +3 more

Dr. Faraz Pathan is a Senior Lecturer at Sydney Medical School and a cardiologist specializing in cardiovascular imaging. Based at Nepean Hospital, he serves as Head of Cardiac Imaging and Cardiac Research within the Cardiology Department. University of New South Wales (2006), First Class Honours His research focuses on precision phenotyping of cardiovascular pathophysiology using Cardiac Magnetic Resonance (CMR), atrial strain as a cardiovascular outcome predictor, appropriate cardiac imaging use, heart failure readmission reduction, and health economics applications in cardiology. Key trends in his 2021-2025 publications include multimodality imaging techniques, atrial strain analysis, chemotherapy-related cardiotoxicity, and obesity-related cardiovascular imaging challenges. Collaborative projects span institutions like Goethe Institute Frankfurt and Menzies Institute for Medical Research. Scientific recognition includes the Ten of the Best research award from Menzies Institute for Medical Research. Grants highlight his work in microvascular restoration (REDUCE trial), obesity-cardiovascular interactions, and cardiac inflammation mapping. He leads a nine-researcher team in echocardiography quality improvement, atrial strain analysis, heart failure protocols, and health economics studies. International collaborations with Goethe Institute Frankfurt and Menzies Institute for Medical Research demonstrate his global research impact, particularly in experimental cardiovascular imaging and translational studies.

Dirk M. HermannView profile

Professor

• ATP-binding cassette transporters in the ischemic brain
• Diseases of the peripheral nervous system
• Clinical and Experimental Neuroimmunology
• +7 more

Prof. Dr. Dirk M. Hermann serves as a leading academic at the Clinic for Neurology within University Hospital Essen. His research focuses on vascular neurology, dementia research, and aging-related neurological disorders , with particular emphasis on ATP-binding cassette transporters, thromboinflammation, and restorative therapies for ischemic brain injury. Key research themes include neurovascular remodeling , neuronal-glial interactions , and secondary neurodegeneration following stroke. His recent publications highlight 2024 work on extracellular vesicles in brain plasticity , 2022 studies on post-stroke myeloid cell dynamics , and 2020 clinical trial design contributions in stroke recovery. His research integrates neuroimmunology with molecular cell biology to address stroke pathophysiology and recovery mechanisms. Collaborative projects span cardio-neurovascular interactions and nanoparticle neurodelivery systems , particularly evident in 2020 biomaterials research.

• Vascular Health in Chronic Kidney Disease
• Arterial Stiffness
• Hypertension
• +6 more

Mohsen Agharazii is a Clinical Physician and Full Professor at the Faculty of Medicine, Laval University. Affiliated with the Research Center of the CHU de Québec - Université Laval, his work focuses on vascular health in chronic kidney disease (CKD), arterial stiffness, hypertension, and numerical simulation models for biomechanical analysis. He has led major funded projects, including RENEW-HD (vascular health in hemodialysis) and Néphro-psy (psychosocial aspects of CKD). Current Funding: RENEW-HD (2025-2027), NéphroPsy (2024-2026), RETAME-PA (2024-2027), and others Past Funding: CARTESIAN (CVD in CKD), CENTRAL-CKD (blood pressure targets), and studies on arterial stiffness His recent research explores subclinical primary aldosteronism as a cardiovascular risk modifier, vascular aging in dialysis patients, and bone-vascular interactions post-transplantation. Collaborative work spans institutions like University of British Columbia, Université de Montréal, and McGill University. No scientific awards are explicitly mentioned. Supervisions: 8 active and completed PhD and Master’s students in clinical sciences, physics, and kinesiology Labs: Research Center of the CHU de Québec - Université Laval

Dagmar Führer-SakelView profile

Professor

• Endocrinology
• Thyroid Hormone Action
• Thyroid Cancer
• +6 more

Prof. Dr. Dr. med. Dagmar Führer-Sakel is a full Professor and Director of the Clinic for Endocrinology, Diabetology and Metabolism at the University Hospital Essen, affiliated with the University of Duisburg-Essen (Faculty of Medicine). She leads the research group 'Thyroid Hormone Action' and is a key member of the Zentrum für Molekulare Biomedizin (ZMB), contributing to oncology and molecular endocrinology research programs. Her research focuses on thyroid hormone action , with particular emphasis on thyroid cancer, cardiovascular implications of thyroid disorders, aging-related thyroid dysfunction, and metabolic effects. Her work spans both clinical and basic research, utilizing mouse models, human cohort studies, and international collaborations. She has made significant contributions to understanding thyroid hormone transport, receptor signaling, and therapeutic strategies in Graves' orbitopathy and differentiated thyroid cancer. The recent publications (2018–2025) reflect a strong trend in thyroid endocrinology , cardiovascular risk assessment , and patient-centered outcomes in thyroid cancer. Her studies frequently appear in top journals such as Thyroid , The Lancet Diabetes & Endocrinology , and Circulation , demonstrating high impact and interdisciplinary reach. Active participant in international consensus guidelines (ATA, EANM) Principal investigator in multicenter clinical trials (e.g., MINGO study) Key contributor to large-scale meta-analyses on thyroid function and cardiovascular risk Research integrated into clinical practice at a leading university hospital She supports young scientists through doctoral and clinician-scientist programs and leads a multidisciplinary team of physicians, scientists, and medical staff. Although no individual scientific awards are listed for her personally, her clinic has received recognition for excellence in care and research. She is actively mentoring the next generation of endocrinologists and researchers, with a strong publication record indicating ongoing supervision of students and postdoctoral fellows. Her laboratory and clinical team investigate thyroid hormone signaling, metabolic impacts of endocrine disorders, and translational applications in oncology and cardiovascular medicine. The research group is embedded within a robust network of national and international collaborators, including institutions in Dortmund, the Netherlands, and the US.

İRFAN VEYSEL DÜZENView profile

Associate Professor

• Cardiology
• Internal Medicine
• Cardiovascular Diseases
• +3 more

İrfan Veysel DÜZEN is an Associate Professor at the Faculty of Medicine, Department of Internal Medical Sciences at Gaziantep University , Türkiye. He holds a Doctorate in Medical Biology and Genetics (2016-2020) and completed his Medical Specialization (2005-2010) and Medical License (1997-2003) at Ankara and Hacettepe Universities, respectively. Education: PhD, Medical Specialization, MD Membership: Turkish Society of Cardiology Research Certifications: Experimental Animal Practice, Study Skills Research Interests focus on cardiovascular diseases , particularly genetic/molecular mechanisms in heart failure, oxidative stress, and interventional outcomes. His work bridges clinical cardiology , echocardiography , and metabolic syndrome analysis. He has authored 4 books and 53 peer-reviewed articles (last updated 2025), with a strong emphasis on SCI/SCI-Expanded journals. His 15 most recent articles (2025-2021) explore topics such as: Hashimoto's Thyroiditis and cardiac strain Gastrointestinal bleeding in cardiovascular patients Novel biomarkers in heart failure (NRF2, glycogen synthase) Gene mutations in cardiomyopathy Radiation safety in interventional cardiology Thromboembolic risks in peripheral artery interventions Teaching and Leadership includes 8 lectures on cardiology topics (2018-2019) and participation in 15 international/national conferences, including the World Congress of Cardiology (2012) and 17th European Congress of Endocrinology (2015). He has advised on a 2022 medical specialization thesis and collaborated with 20+ researchers across Türkiye.

Sara BergstrandView profile

Assistant Professor

• Microcirculation
• Optical Measurement Techniques
• Translational Medicine
• +6 more

Sara Bergstrand is an Assistant Professor and Head of Unit at Linköping University's Department of Nursing and Reproductive Health (ORH), Faculty of Medicine. She directs the Graduate School of Close Care in the Southeastern Healthcare Region, focusing on interdisciplinary research at the interface of medical technology, translational medicine, and nursing science. Research spans microcirculation, optical measurement techniques, and translational applications Key projects: Early detection of pressure ulcers, hypertensive pregnancy complications, and SCAPIS Micro Teaching includes wound healing courses and supervision of nursing/medical students Her recent publications (2023-2025) analyze microcirculatory dysfunction in diabetes, pregnancy complications, and wound healing using optical spectroscopy. Awards include collective research funding from the Swedish Research Council (42.6M SEK for graduate school development). Collaborations span cardiovascular diabetology, biomedical optics, and clinical nursing implementation. Notable contributions include developing optical methods for tissue assessment and establishing translational frameworks between experimental research and clinical practice. Current initiatives focus on population-based microcirculatory risk profiling and multi-disciplinary healthcare optimization.

• Cardiology
• Atrial Fibrillation Management
• Cardiovascular Devices
• +5 more

Jeffrey Sean Healey is a Professor of Medicine at McMaster University , affiliated with the Faculty of Health Sciences . His research focuses on cardiovascular diseases, particularly atrial fibrillation, defibrillator technology, anticoagulant therapies, and clinical trial design. He leads studies on stroke prevention, device safety, and arrhythmia management. He has contributed to major trials like RE-LY and ASSERT, investigating novel oral anticoagulants and subclinical atrial fibrillation detection. His work spans device innovation, pharmacological interventions, and improving patient outcomes through evidence-based strategies. Recent studies include analyses of alcohol's role in cardiovascular outcomes, mineralocorticoid receptor antagonists' effects, and prediction models for ventricular tachycardia. He has authored over 375 scholarly works in the last decade, with a focus on atrial fibrillation epidemiology and device-related complications.

Ayça TürerView profile

Associate Professor

• Cardiology
• Heart Disease
• Myocardial Infarction
• +5 more

Assoc. Prof. Dr. Ayça Türer is an Associate Professor of Cardiology at Yeditepe University Faculty of Medicine, Department of Cardiology. She has been serving as a Doctoral Academic Staff member since 2014 at Yeditepe University, Faculty of Medicine, Department of Internal Medicine Sciences, Cardiology Department. Dr. Türer's educational background includes undergraduate medical education from Ankara University Faculty of Medicine (1999-2005), medical specialization in cardiology at Istanbul Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital (2006-2011), and a doctorate in Molecular Medicine from Yeditepe University Institute of Health Sciences. Her research interests focus on cardiology, particularly myocardial infarction, heart failure, electrocardiography, coronary artery disease, and cardiac biomarkers. She has made significant contributions to understanding prognostic factors in acute coronary syndromes, cardiac imaging techniques, and the relationship between cardiovascular diseases and other systemic conditions. Dr. Türer has published numerous articles in high-impact cardiology journals, with her most recent work focusing on asymmetric dimethylarginine levels in pulmonary hypertension, biomarkers for left ventricular hypertrophy, and novel electrocardiographic patterns for diagnosing myocardial infarction. Her research demonstrates a strong emphasis on clinical applications and diagnostic improvements in cardiovascular medicine. She is an active member of professional organizations including the European Association of Cardiovascular Imaging (since 2018), European Society of Cardiology (since 2016), and Turkish Cardiology Association (since 2014). Dr. Türer has taught various cardiology courses at the undergraduate level, including Heart Failure, Cardiomyopathies, Valvular Heart Diseases, and cardiovascular examination techniques, all delivered in English. She has also authored several books in cardiology, including the "Cardiology Survival Guide" and "Heart Diseases in Women".

Franklin BrownView profile

Associate Professor

• Neurology
• Neuropsychology
• Visual Memory
• +12 more

Franklin Brown is an Associate Professor of Clinical Neurology at Yale University, affiliated with the Yale School of Medicine and the Division of Neuropsychology. His clinical work focuses on patients with brain tumors, epilepsy, cancer-related cognitive complaints, multiple sclerosis, and brain injuries. He is renowned for developing the internationally used Brown Location Test (BLT) and the STEPS sleep treatment program , which address cognitive assessment and student sleep education, respectively. Education: PhD (Louisiana Tech University, 2002), MA (Kutztown University of Pennsylvania, 1996), BA (Kutztown University of Pennsylvania, 1994) His research spans visual memory , cognitive inefficiency , and their applications in epilepsy and multiple sclerosis , with a focus on improving diagnostic accuracy and understanding subcortical stroke impacts. Recent publications highlight trends in neuropsychological testing , sleep research , and cognitive biomarkers for neurological diseases. Collaborations include Yale Cancer Center, Pediatric Epilepsy Program, and Yale Ventures. He volunteers on boards (AACN & AACNF), reviews certifications, and advocates for diversity in neuropsychology.